戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e if a single dose of postoperative adjuvant intraarterial (131)I-lipiodol (vs. unlabeled lipiodol) c
2 n age of 63 y [range, 23-85 y]): 29 received intraarterial (131)I-lipiodol and 29 received lipiodol a
3  of patients with HCC, one 2,200-MBq dose of intraarterial (131)I-lipiodol significantly decreased th
4 f patients including 24% cardiac origin, 14% intraarterial, 2% cardiac and arterial sources).
5           The first 5 patients also received intraarterial (68)Ga-DOTATOC and underwent PET/CT.
6  patients who underwent both intravenous and intraarterial (68)Ga-DOTATOC PET/CT, tumor SUV(max) was
7 PET for quantifying metabolic response after intraarterial (90)Y-glass microspheres for metastatic co
8 MRI, (18)F-FDG PET, hepatic angiography, and intraarterial (99m)Tc-labeled macroaggregated albumin sc
9  change in forearm blood flow in response to intraarterial acetylcholine and nitroprusside in 10 long
10 ependent blood flow with increasing doses of intraarterial acetylcholine.
11                        Patients who received intraarterial administration failed to demonstrate highe
12 UV(max) was compared between intravenous and intraarterial administration for hepatic tumors, intrahe
13                                Ex vivo renal intraarterial administration is a targeted delivery meth
14                                     Results: Intraarterial administration of (89)Zr-BVDFO resulted in
15 ients, we aimed to determine whether hepatic intraarterial administration of (90)Y-DOTATOC peptide re
16       Vascularised lesions were embolised by intraarterial administration of a mixture of bleomycin a
17  assessed by forearm blood flow responses to intraarterial administration of acetylcholine and bradyk
18         Consistent with these results, after intraarterial administration of AdSM22-lacZ to control a
19                             While especially intraarterial administration of contrast media represent
20 and after treatment, blood flow responses to intraarterial administration of endothelium-dependent (a
21 ts, is not statistically different after the intraarterial administration of iopamidol or iodixanol t
22 ere drawn at baseline and in response to the intraarterial administration of isoproterenol (400 ng/mi
23                 This study demonstrates that intraarterial administration of TNK-tPA at 2 h of ischem
24  for each drug before and during concomitant intraarterial administration of vitamin C (24 mg/min).
25 ighest ratio was found in the tumor near the intraarterial administration site.
26                In 1 rat, the effect of local intraarterial administration was examined.
27 ean, +220%) and SPECT/CT (mean, +398%) after intraarterial administration, compared with intravenous
28   We aimed to investigate the added value of intraarterial administration.
29 rinolytic function were assessed by means of intraarterial agonist infusions.
30 rescence was seen in tumors 30 minutes after intraarterial and intraportal injection and was statisti
31                                    Recently, intraarterial application of the radiolabeled somatostat
32 rized by the plaque formation that restricts intraarterial blood flow.
33                    We studied the changes in intraarterial blood pressure (BP), heart rate (HR), cent
34 different day, in all subjects we determined intraarterial blood pressure, EKG and muscle sympathetic
35                                              Intraarterial blood pressure, heart rate, and simultaneo
36 elines recommend GLP-1R imaging or selective intraarterial calcium stimulation and venous sampling (A
37                    Sa (O(2)) was measured by intraarterial catheter, pulmonary capillary wedge pressu
38 a long procedure and careful placement of an intraarterial catheter.
39                             Neurotoxicity of intraarterial cerebral chemotherapy can be minimized by
40 s, which include transarterial embolization, intraarterial chemoinfusion, transarterial chemoemboliza
41 h IIPCSs before being treated with biweekly, intraarterial chemotherapy (oxaliplatin, 5-Flourouracil,
42                                              Intraarterial chemotherapy for brain tumors is a safe pr
43                 Finally, the introduction of intraarterial chemotherapy for human intraocular retinob
44 ebral angiographic procedures accompanied by intraarterial chemotherapy were performed in 48 patients
45 luded an image obtained near the peak of the intraarterial concentration of contrast agent (enhanceme
46  Gadodiamide appears to be a safe and useful intraarterial contrast agent in patients with renal insu
47 diamide (total dose, 0.3 mmol/kg) and CO2 as intraarterial contrast agents in 25 procedures in 24 pat
48  treatment and compare them with those after intraarterial control injections of saline.
49 p without urethral cooling (P = .002), while intraarterial cooling demonstrated a nonsignificant tren
50                           The application of intraarterial cooling did not provide a significant impr
51                                              Intraarterial CT was performed using 64-slice scanner.
52                           Ultra-low contrast intraarterial CT-angiography does not deteriorate the fu
53                                              Intraarterial CT-angiography is useful for detection of
54      MATERIAL/METHODS: Between 2010 and 2013 intraarterial CT-angiography was performed in 56 patient
55 u-HA-DOTATATE treatment first and subsequent intraarterial cycles.
56                     However, a rationale for intraarterial delivery and BBB opening when delivering a
57                                     Targeted intraarterial delivery and homing of VLA-4-expressing hG
58    Significantly, we report here that direct intraarterial delivery of 3-bromopyruvate (3-BrPA), a po
59                                        Thus, intraarterial delivery of agents like 3-BrPA directly to
60    Conclusion: Our findings demonstrate that intraarterial delivery of bevacizumab into the brain acr
61      A method facilitating quantification of intraarterial delivery of bevacizumab is needed for more
62                       Results After surgical intraarterial delivery of TNBC cells, rats developed tum
63  a novel drug development approach combining intraarterial drug delivery and microdosing.
64                The mean total direct cost of intraarterial DSA (+/- SD) was $1,052 +/- 71, and that o
65  Interobserver agreement was substantial for intraarterial DSA (kappa = 0.73; 95% CI: 0.64, 0.82) and
66 ve patients who were scheduled for follow-up intraarterial DSA after coil placement were invited for
67 the variable direct costs of performing nine intraarterial DSA and 10 CT angiographic examinations in
68 ng was suggested for 37 patients (12%) after intraarterial DSA and for 49 patients (16%) after MR ang
69 Agreement between treatment advices based on intraarterial DSA and MR angiographic findings and inter
70 rgo additional treatment is similar based on intraarterial DSA and MR angiographic findings, with onl
71                         With 95% confidence, intraarterial DSA cost 3.2-3.7 times more than CT angiog
72    In six patients (2%), the advice based on intraarterial DSA findings was additional treatment, whi
73 as additional treatment, while that based on intraarterial DSA findings was extended follow-up imagin
74  savings whenever CT angiography can replace intraarterial DSA for imaging AAAs.
75     One hundred forty-two patients underwent intraarterial DSA to detect aneurysms.
76 mensional time-of-flight MR angiography, and intraarterial DSA were performed contemporaneously.
77                            Agreement between intraarterial DSA- and MR angiography-based treatment re
78                                              Intraarterial embolism was the commonest mechanism of br
79 ively test the hypothesis that transcatheter intraarterial first-pass perfusion (TRIP) magnetic reson
80 s to lumbar sympathetic nerve stimulation or intraarterial hindlimb infusion of the specific alpha2-a
81 rse of hemodynamic and metabolic response to intraarterial (IA) mannitol infusions in order to optimi
82             BBB opening with mannitol before intraarterial infusion of (89)Zr-BVDFO resulted in faste
83  responses (strain gauge plethysmography) to intraarterial infusion of a selective blocker of ET(A) r
84        Forearm blood flow (FBF) responses to intraarterial infusion of acetylcholine (ACh; 7.5, 15, a
85  at 15 min postinjury, received a continuous intraarterial infusion of AK295 (120-140 mg/kg, n = 15)
86        Forearm blood flow (FBF) responses to intraarterial infusion of an ET(A) receptor blocker (BQ-
87 has been recently demonstrated that a single intraarterial infusion of bevacizumab provides superior
88 e achieved through opening of the BBB before intraarterial infusion of bevacizumab.
89    In response to activation of platelets by intraarterial infusion of collagen, blood flow to the le
90 elium-dependent vasodilation was assessed by intraarterial infusion of methacholine (0.3 to 10 microg
91 elium-dependent vasodilation was assessed by intraarterial infusion of methacholine (0.3-10 microgram
92        In summary, the beneficial effects of intraarterial infusion of MSCs are amplified with intrav
93 ium-independent vasodilation was assessed by intraarterial infusion of nitroprusside (0.3 to 10 micro
94 ium-independent vasodilation was measured by intraarterial infusion of nitroprusside (0.3-10 microgra
95 gher frequency of hemorrhagic complications, intraarterial infusion of urokinase reduced the need for
96 ion (43 patients) via intravenous or hepatic intraarterial infusion.
97 ministrations of (90)Y microspheres by using intraarterial infusion.
98         Vascular function was assessed using intraarterial infusions (3 progressive doses) of acetylc
99 lethysmography) was measured during brachial intraarterial infusions of ACh (endothelium-dependent ag
100 d vascular conductance was calculated during intraarterial infusions of phenylephrine and clonidine.
101 d vascular conductance was calculated during intraarterial infusions of the alpha1-agonist phenylephr
102 erentially in the lungs after intravenous or intraarterial injection (10.9 +/- 0.7 and 11.0 +/- 1.5 v
103                                Postoperative intraarterial injection of (131)I-labeled lipiodol has b
104 f mannitol alone in PBS (1.5 g/kg); group 3, intraarterial injection of 1 million hBMSCs alone in PBS
105 on of mannitol (1.5 g/kg) in PBS followed by intraarterial injection of 1 million hBMSCs in PBS.
106 s (N=9): group 1, negative control with only intraarterial injection of 1 million human fibroblasts i
107                                              Intraarterial injection of 3-BrPA resulted in markedly d
108 , all patients underwent SPECT imaging after intraarterial injection of 37 MBq of (99m)Tc-macroaggreg
109                                        After intraarterial injection of an MPO-specific (di-5-hydroxy
110  inversion recovery-prepared technique after intraarterial injection of contrast material in five dog
111 f intact animals after either intravenous or intraarterial injection.
112 ntrast material-enhanced MR angiography with intraarterial injections is feasible with the proposed t
113                                              Intraarterial injections of small doses of gadopentetate
114  to 13.2+/-0.96 pmol/ml, P < 0.01); however, intraarterial L-NAME decreased basal cGMP secretion 66%
115       After E2beta-induced increases in UBF, intraarterial L-NAME partially decreased UBF dose depend
116                                              Intraarterial microdosing (IAM) is a novel drug developm
117 ly affected, necessitating the use of direct intraarterial monitoring.
118 sis that mannitol improves the efficiency of intraarterial MSC delivery (i.e., fewer injected cells r
119                              We demonstrated intraarterial MSC infusion to transplant kidneys as a sa
120                                              Intraarterial NAC did not change resting coronary or per
121 e and two with head trauma who had undergone intraarterial or intravenous administration of iodinated
122 icity in patients who have recently received intraarterial or intravenous iodinated contrast material
123                Future prospective studies on intraarterial peptide receptor radionuclide therapy are
124                                  Conclusion: Intraarterial peptide receptor radionuclide therapy sign
125 ed by EEG silence with either intravenous or intraarterial propofol.
126                                  Conclusion: Intraarterial PRRT in patients with advanced meningioma
127 tudy, we assessed the safety and efficacy of intraarterial PRRT in patients with advanced, progressiv
128 a underwent 1-4 cycles (median, 4 cycles) of intraarterial PRRT with [(177)Lu]Lu-HA-DOTATATE (mean ac
129 h advanced, progressive meningioma underwent intraarterial PRRT with [(177)Lu]Lu-HA-DOTATATE.
130 gery) with thrombolysis by catheter-directed intraarterial recombinant urokinase; all patients (272 p
131                    In this controlled trial, intraarterial revascularization with stents was an effec
132 en fluorodeoxyuridine (FUDR) is given by the intraarterial route for the treatment of unresectable co
133             With the criteria developed, the intraarterial secretin test had high specificity but low
134                                              Intraarterial secretin test results assisted in clinical
135                           Sensitivity of the intraarterial secretin test was 41%; of CT and ultrasoun
136 g, ultrasound, abdominal angiography, and an intraarterial secretin test, in which venous blood is sa
137 aneous intravenous sensing, blood draws, and intraarterial sensing, we found that intraperitoneal kin
138 f endothelial cells to the steel surfaces of intraarterial stents because of the following mechanisms
139 r deliver more targeted chemotherapy via the intraarterial technique.
140                                Transcatheter intraarterial therapies have proved valuable in the batt
141            The concept of all catheter-based intraarterial therapies is to selectively deliver antica
142                                              Intraarterial therapy allows the delivery of a high dose
143 ents with hepatocellular carcinoma underwent intraarterial therapy between October 2005 and February
144                               Specificity in intraarterial therapy can be achieved both through prefe
145 ber 2008, 491 consecutive patients underwent intraarterial therapy for liver cancer with either conve
146                                              Intraarterial therapy options for colorectal liver metas
147 nctional MR response 3-4 weeks after initial intraarterial therapy showed improved OS.
148  hours after onset, to endovascular therapy (intraarterial thrombolysis with recombinant tissue plasm
149 ns were studied in 32 patients who underwent intraarterial thrombolysis with urokinase within 6 hours
150 tients undergoing vessel recanalization with intraarterial thrombolytics.
151 ed intravenous administration, with a median intraarterial-to-intravenous SUV(max) ratio of 0.81 (ran
152                To evaluate the safety of MSC intraarterial transplantation, naive pigs (n = 3) were u
153 anial occlusion of the anterior circulation, intraarterial treatment administered within 6 hours afte
154  centers in The Netherlands (233 assigned to intraarterial treatment and 267 to usual care alone).
155  a proximal intracranial arterial occlusion, intraarterial treatment is highly effective for emergenc
156 andomly assigned eligible patients to either intraarterial treatment plus usual care or usual care al
157 mmon odds ratio measured the likelihood that intraarterial treatment would lead to lower modified Ran
158  190 of the 233 patients (81.5%) assigned to intraarterial treatment.
159 s to either sympathetic nerve stimulation or intraarterial UK 14,304.
160                                              Intraarterial ultra-low volume of contrast medium result
161 round organs (secondary aim, intravenous vs. intraarterial uptake).
162 However, substantial data are lacking on the intraarterial use of gadolinium in patients with renal i
163                  These findings suggest that intraarterial vasodilator therapy fails to improve intes
164 ever, the authors have previously found that intraarterial vasodilators actually reduce collateral bl
165 py included local treatment and injection of intraarterial vasodilators.
166 olamine, topical nitroglycerin ointment, and intraarterial verapamil and nitroglycerin.

 
Page Top